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Ventilator associated events... perhaps not the answer  
Richard Pugh, Wendy Harrison, Ceri Battle, Chris Hancock, Tamas Szakmany 
In the most recent issue of JICS, Dr Thomas has rightly argued that ventilator-associated pneumonia 
(VAP) can be difficult to diagnose and that efforts to limit ventilator-associated morbidity must 
extend beyond VAP prevention (1). We share his concerns, but are unconvinced that adopting the 
CDC NHSN ventilator-associated event (VAE) surveillance system recently introduced in the United 
States (2) is currently the right approach for our population (3). 
 
In Wales, there has been a national surveillance programme to identify episodes of VAP since 2008, 
originally using the Hospitals in Europe Link for Infection Control through Surveillance definitions 
(HELICS, classified as PN 1 to 5, according to radiological, systemic, pulmonary and microbiological 
criteria). We recently investigated triggers for initiating antibiotic therapy for suspected ventilator-
associated respiratory tract infection (VARTI) and the implications of variation in clinical practice for 
VAP surveillance (4). Among 282 invasively ventilated patients admitted to ICU for 48 hours or more, 
33 developed VARTI – the main features having been volume and purulence of sputum, 
inflammatory markers and radiographic changes. In less than 50% cases was chest radiography 
performed at time of diagnosis, which precludes diagnosis of VAP according to HELICS definition – 
though these episodes were associated with a significantly prolonged duration of mechanical 
ventilation and ICU stay. 
 
However, applying the new CDC NHSN definitions to our cohort, we found no overlap between VAE 
and suspected VARTI. Outside of the UK, other investigators have also described potential limitations 
to VAE surveillance. A ventilator-associated complication (VAC) is identified when there is sustained 
increase in FiO2 or PEEP after a stable baseline of 48 hours or more. However, many patients do not 
meet the definition of VAC because fluctuations in FiO2 and PEEP prevent them achieving this stable 
baseline (5). Variations in practice may affect whether a patient develops a VAC depending on 
preference for PEEP level or ventilator mode, such as APRV. Previous studies have also found low 
level of agreement between episodes of VAC and VAP; indeed patients meeting VAC criteria have a 
range of pathology which might include VAP, but alternatively may represent fluid overload, ARDS  
or atelectasis. Interventions required to prevent and treat such heterogeneous pathology are likely 
to differ and it may be difficult to understand the contribution of different processes to patient 
outcomes associated with VAC.  
 There are distinctions between the diagnostic needs of the clinician at the bedside and the 
surveillance administrator - and it is possible to perceive a risk of disengagement with a quality 
improvement programme that does not emphasise clinical discrimination. Furthermore, although 
VAE data is highly objective, in a paper-based clinical environment, the workload associated with 
screening should not be underestimated. Our approach has not been to dispense with HELICS 
definitions of VAP at this stage, but – appreciating the variation in performance of chest x-ray and 
subjectivity in interpretation – to supplement with an additional category ͞PN0͟ where there is 
pulmonary, systemic and microbiological evidence of VARTI but without radiographic evidence. We 
look forward to reporting further on this issue. 
 
References 
1. Thomas M. Ventilator associated events should trump ventilator associated pneumonia. Journal of 
the Intensive Care Society, 2016; 17(4): 358. 
2. Magill SS, Klompas M, Balk R, et al. Developing a new, national approach to surveillance for 
ventilator-associated events. Crit Care Med 2013;41(11):2467–75. 
3. Pugh R, Szakmany T. Ventilator-associated pneumonia surveillance: complex, complicated and still 
searching for the right tool. British Journal of Intensive Care 2014; 24(1):20-25 
4. Pugh R, Harrison W, Harris S, et al. Is HELICS the right way? Lack of chest radiography limits 
ventilator-associated pneumonia surveillance in Wales. Frontiers in Microbiology 2016; 7:1271 
5. Fan Y, Gao F, Wu Y, Zhang J, Zhu M, X L. Does ventilator-associated event surveillance detect 
ventilator-associated pneumonia in intensive care units? A systematic review and meta-analysis. 
Critical Care 2016; 20:338 
 
